Get started

Financials · OMDA

Omada Health Inc. (OMDA) financials

For the twelve months ended Sep 30, 2026, Omada Health Inc. reported $333.04M of revenue and $14.03M of net income.

Revenue, TTM
$333.04M
Revenue growth, YoY
+43.3%
Net income, TTM
$14.03M
Net margin
4.2%
Free cash flow, TTM
$28.15M
Cash
$243.15M
P/E
65.82
P/S
2.77
Market cap
$923.8M
Annual revenue$260.21M
FY2023FY2025
Annual net income-$12.78M
FY2023FY2025
Annual free cash flow$16.93M
FY2023FY2025

OMDA revenue and earnings growth

OMDA revenueQ3 2026$91.31M

Quarter YoY
+34.2%
QoQ
+4.0%
FY YoY
+53.2%

OMDA revenue was $91.31M in fiscal Q3 2026 (ended Sep 30, 2026), up 34.2% from a year earlier and up 4.0% from the prior quarter. For the full fiscal 2025 it was $260.21M, up 53.2% from fiscal 2024.

OMDA net incomeQ3 2026$6.55M

QoQ
+23.7%

OMDA net income was $6.55M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$3.18M a year earlier and up 23.7% from the prior quarter. For the full fiscal 2025 it was -$12.78M, compared with -$47.14M in fiscal 2024.

OMDA EPSQ3 2026$0.10

QoQ
+25.0%

OMDA diluted EPS was $0.10 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.06 a year earlier and up 25.0% from the prior quarter. For the full fiscal 2025 it was -$0.35.

OMDA free cash flowQ3 2026$15.02M

Quarter YoY
+56.5%
QoQ
+289.1%

OMDA free cash flow was $15.02M in fiscal Q3 2026 (ended Sep 30, 2026), up 56.5% from a year earlier and up 289.1% from the prior quarter. For the full fiscal 2025 it was $16.93M, compared with -$34.77M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
Revenue$260.21M$169.80M$122.78M
Cost of revenue$89.27M$66.92M$52.81M
Gross profit$170.94M$102.88M$69.97M
Research and development$40.68M$35.92M$33.74M
Selling, general and admin$52.18M$42.55M$35.98M
Operating income-$11.97M-$43.65M-$66.00M
Interest expense$2.53M$4.51M$4.71M
Pre-tax income-$12.78M-$47.14M-$67.51M
Income tax$0$0$0
Net income-$12.78M-$47.14M-$67.51M
EPS, basic-$0.35-$6.11-$9.52
EPS, diluted-$0.35-$6.11-$9.52
Diluted shares36.6M7.7M7.1M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
Cash and equivalents$222.04M$76.39M$115.64M
Receivables$34.59M$23.42M-
Inventory$4.49M$3.30M-
Current assets$272.93M$113.06M-
Goodwill$13.24M$13.24M-
Total assets$305.41M$150.89M-
Current liabilities$75.73M$53.95M-
Total debt$0$29.77M-
Total liabilities$75.73M$86.26M-
Shareholders' equity$229.68M-$384.40M-$350.11M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
Operating cash flow$18.25M-$34.18M-$49.74M
Capital expenditures$1.32M$596.0K$416.0K
Free cash flow$16.93M-$34.77M-$50.15M
Investing cash flow-$5.83M-$3.86M-$2.92M
Financing cash flow$133.22M-$1.21M$179.0K
Stock-based compensation$12.96M$9.42M$8.74M
Depreciation and amortization$5.49M$4.80M$4.45M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
Revenue growth, YoY53.2%38.3%-
Gross margin65.7%60.6%57.0%
Operating margin-4.6%-25.7%-53.8%
Net margin-4.9%-27.8%-55.0%
Free cash flow margin6.5%-20.5%-40.8%
Return on equity-5.6%--
Return on assets-4.2%-31.2%-
Current ratio3.602.10-
Debt to equity0.00--

Source: XBRL data Omada Health Inc. files with the SEC, latest filing dated Nov 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

OMDA peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
OMDA$333.04M+43.3%$14.03M4.2%$923.8M
BTSG$15.25B+26.0%$410.27M2.7%$13.76B
CHE$2.66B+5.2%$282.40M10.6%$7.00B
LFST$1.68B+22.6%$71.91M4.3%$5.55B
HIMS$2.87B+29.8%-$190.84M-6.7%$5.35B
OPCH$5.75B+4.0%$215.19M3.7%$4.75B
PRVA$2.43B+19.2%$36.08M1.5%$3.14B
AVAH$2.60B+19.5%$274.76M10.6%$2.88B
ADUS$1.50B+11.5%$111.05M7.4%$2.28B

OMDA FAQ

8 questions
  • What is OMDA revenue?
    Omada Health Inc. (OMDA) reported $333.04M of revenue for the twelve months ended Sep 30, 2026. That is up 43.3% from the year before. Revenue for fiscal 2025 was $260.21M.
  • Is OMDA profitable?
    Yes. Omada Health Inc. earned $14.03M in net income for the twelve months ended Sep 30, 2026, a net margin of 4.2%.
  • How much cash and debt does OMDA have?
    Omada Health Inc. reported $243.15M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is OMDA revenue growing?
    Omada Health Inc.'s revenue changed +53.2% in fiscal 2025, to $260.21M.
  • What is OMDA gross margin?
    Omada Health Inc.'s gross profit was $235.42M on $333.04M of revenue for the twelve months ended Sep 30, 2026, a gross margin of 70.7%.
  • What is OMDA free cash flow?
    Omada Health Inc. generated $28.15M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $28.69M less capital expenditures.
  • When did OMDA last report financial results?
    The latest statements here come from Omada Health Inc.'s 10-Q filed on Nov 6, 2026, covering the period ended Sep 30, 2026.
  • Where does this OMDA financial data come from?
    Quantisnow builds these statements from the structured XBRL data Omada Health Inc. files with the SEC. It is provided for information only and is not investment advice.